At diagnosis, the median PRL was 6305 μg/L (range 1450-253 000), the median tumor diameter was 47 mm (range 40-85), 84% of the patients had hypogonadotropic hypogonadism, and 71% visual field defects. The gene discussed is PRL; the disease is hypogonadotropic hypogonadism.